In a significant advancement for healthcare diagnostics in India, Bengaluru-based biotechnology startup CrisprBits has unveiled a state-of-the-art CRISPR diagnostics laboratory dedicated to rare disease detection. The facility, equipped with advanced gene-editing technology, aims to revolutionize...
In a significant advancement for healthcare diagnostics in India, Bengaluru-based biotechnology startup CrisprBits has unveiled a state-of-the-art CRISPR diagnostics laboratory dedicated to rare disease detection. The facility, equipped with advanced gene-editing technology, aims to revolutionize the diagnosis of rare genetic conditions, making testing more accessible and efficient for patients across the country. This pioneering initiative marks a crucial step forward in India's biotechnology sector, promising faster and more accurate diagnostic solutions for rare disease patients.
Source: CrisprBits Press Release